Drug Efficacy - AstraZeneca's experimental hypertension pill demonstrated a blood pressure reduction more than twice that of standard treatment in a large late-stage study [1] Competitive Landscape - The study results enhance AstraZeneca's prospects for competing in a crowded hypertension treatment market [1]

What's your view that the FDA does not have authority in this moment, your wellness, not medical device. Well, thanks for having me on. You know, you've spent the last three years developing a very innovative feature called Blood Pressure Insights, and this takes our wrist worn wearable alongside a calibration with a cuff and is allowed to provide you with a daily estimate of your blood pressure.And in turn, it also then gives you insights how your blood pressure may be affecting other things in your wellne ...